Andrew Lewin

Andrew Lewin

UNVERIFIED PROFILE

Are you Andrew Lewin?   Register this Author

Register author
Andrew Lewin

Andrew Lewin

Publications by authors named "Andrew Lewin"

Are you Andrew Lewin?   Register this Author

41Publications

766Reads

17Profile Views

Genomic, Recombinational and Phylogenetic Characterization of Global Feline Herpesvirus 1 Isolates.

Virology 2018 05 30;518:385-397. Epub 2018 Mar 30.

McPherson Eye Research Institute, University of Wisconsin-Madison, Wisconsin, USA; Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Wisconsin, USA; Department of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin-Madison, Wisconsin, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00426822183009
Publisher Site
http://dx.doi.org/10.1016/j.virol.2018.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935452PMC
May 2018

Tonometer validation and intraocular pressure reference values in the normal chinchilla (Chinchilla lanigera).

Vet Ophthalmol 2018 Jan 17;21(1):4-9. Epub 2017 Mar 17.

Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin - Madison, Madison, WI, 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/vop.12468DOI Listing
January 2018

Calibration of the TonoVet and Tono-Pen Vet tonometers in the porcine eye.

Vet Ophthalmol 2017 Nov 24;20(6):571-573. Epub 2016 Nov 24.

School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI, 53706, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/vop.12445DOI Listing
November 2017

Phylogenetic and recombination analysis of the herpesvirus genus varicellovirus.

BMC Genomics 2017 Nov 21;18(1):887. Epub 2017 Nov 21.

Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, 550 Bardeen Laboratories, 1300 University Ave., Madison, WI, 53706, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12864-017-4283-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697016PMC
November 2017

Empagliflozin added to metformin and sulfonylurea therapy in patients with sub-optimally controlled type 2 diabetes mellitus.

Expert Opin Pharmacother 2015 Apr 3;16(5):781-4. Epub 2015 Feb 3.

National Research Institute , 2010 Wilshire Blvd, Suite 302, Los Angeles, CA 90057 , USA . +1 213 413 2500 ; +1 213 486 1494 ;

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.2015.10
Publisher Site
http://dx.doi.org/10.1517/14656566.2015.1009445DOI Listing
April 2015

Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin.

Diabetes Care 2015 Mar 12;38(3):384-93. Epub 2015 Jan 12.

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-2364DOI Listing
March 2015

Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes.

Diabetes Care 2015 Mar 29;38(3):394-402. Epub 2015 Jan 29.

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-2365DOI Listing
March 2015

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.

J Hypertens 2014 Dec;32(12):2488-98; discussion 2498

aOslo University Hospital Ullevaal, University of Oslo, Oslo, Norway bVirginia Commonwealth University, Richmond, Virginia, USA cHannover Medical School, Hannover, Germany dKRK Medical Research Institute, Dallas, Texas, USA eHospital Universitario San Cecilio, Granada, Spain fThe Crouch Oak Family Practice, Surrey, UK gHuisartsenpraktijk De Regenboog, Antwerp, Belgium hNational Research Institute, Los Angeles, California, USA iFondazione S. Maugeri - IRCCS, Pavia jUniversity of Milano-Bicocca, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000000331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227617PMC
December 2014

Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment.

Diab Vasc Dis Res 2014 Jan 29;11(1):34-40. Epub 2013 Oct 29.

Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164113507068DOI Listing
January 2014

Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.

Clin Ther 2013 Feb 15;35(2):142-52. Epub 2013 Jan 15.

National Research Institute, Los Angeles, CA 90057, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014929181200730
Publisher Site
http://dx.doi.org/10.1016/j.clinthera.2012.12.015DOI Listing
February 2013

Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertension.

Adv Ther 2012 Jun 3;29(6):524-37. Epub 2012 Jul 3.

Trinity Hypertension Research Institute, Punzi Medical Center, Carrollton, TX 75006, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12325-012-0029-5
Publisher Site
http://dx.doi.org/10.1007/s12325-012-0029-5DOI Listing
June 2012

Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.

Ther Adv Cardiovasc Dis 2010 Dec;4(6):349-57

Trinity Hypertension & Metabolic Research Institute, 1932 Walnut Plaza, Carrollton, TX 75006, USA.

View Article

Download full-text PDF

Source
http://tak.sagepub.com/content/4/6/349.full.pdf
Web Search
http://tak.sagepub.com/cgi/doi/10.1177/1753944710387629
Publisher Site
http://dx.doi.org/10.1177/1753944710387629DOI Listing
December 2010

Acetylsalicylic acid reduces niacin extended-release-induced flushing in patients with dyslipidemia.

Am J Cardiovasc Drugs 2009 ;9(2):69-79

Abbott Laboratories, Abbott Park, Illinois 60064-6193, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00129784-200909020-00001DOI Listing
June 2009

Basal insulin or premix analogue therapy in type 2 diabetes patients.

Eur J Intern Med 2007 Jan;18(1):56-62

UT Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX, 75390-8858, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095362050600251
Publisher Site
http://dx.doi.org/10.1016/j.ejim.2006.09.006DOI Listing
January 2007

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.

Clin J Am Soc Nephrol 2006 Sep 19;1(5):940-51. Epub 2006 Jul 19.

University of Miami School of Medicine, Miami, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.00240106DOI Listing
September 2006

Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes.

Diabetes Care 2006 Apr;29(4):759-64

Diabetes and Glandular Disease Research Associates, San Antonio, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.29.04.06.dc05-1967DOI Listing
April 2006

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Diabetes Care 2005 Feb;28(2):260-5

Department of Internal Medicine, Southwestern Medical Center at Dallas, Dallas, TX 75390-8858, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.28.2.260DOI Listing
February 2005

The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.

J Clin Hypertens (Greenwich) 2004 Aug;6(8):437-42; quiz 443-4

Merck Research Laboratories, BLX-21, P.O. Box 4, West Point, PA 19486, USA.

View Article

Download full-text PDF

Source
August 2004

The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System.

Diabetes Metab Res Rev 2002 Jan-Feb;18 Suppl 1:S38-42

VP Research and Development, Generex Biotechnology Corporation, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
September 2002

Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension.

Am J Hypertens 2002 Jan;15(1 Pt 1):31-6

The Berman Center for Outcomes and Clinical Research, Minneapolis, Minnesota 55404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0895-7061(01)02224-5DOI Listing
January 2002

Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide.

J Clin Hypertens (Greenwich) 1999 Jul;1(1):22-26

Hypertension Unit, Section of Cardiology, Medical College of Georgia, Augusta, GA.

View Article

Download full-text PDF

Source
July 1999